Position history for Point72 Asset Management, L.P.'s holdings in REGENERON PHARMACEUTICALS
Point72 Asset Management, L.P. holds 262,527 shares of REGN (REGENERON PHARMACEUTICALS), worth $202.6M as of 2025-Q4. The position was increased (++30.3% shares). REGN represents 0.2% of Point72 Asset Management, L.P.'s portfolio.
Current Value
$202.6M
Current Shares
262,527
Total Value Change
+$178.6M
Total Shares Change
+239,656
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 262,527 |
+30.3% |
| $202.6M |
| 0.2% |
| $773.94 |
46 |
| 2025-Q3 | Increased | 201,499 | +40.8% | $113.3M | 0.2% | $560.05 | 48 |
| 2025-Q2 | New | 143,108 | - | $75.1M | 0.1% | $519.56 | 49 |
| 2024-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $1,036.94 | 0 |
| 2024-Q2 | New | 22,871 | - | $24M | 0.1% | $1,045.23 | 40 |